ACSL1

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA011316

Antibody HPA011964

Tissue

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Moderate to strong cytoplasmic staining was observed in malignant lymphomas, prostate, urothelial, renal and liver cancers. Several colorectal, breast, lung and ovarian cancers were moderately stained. Remaining malignant cells were in general weakly stained or negative. Hepatocellular carcinomas and several urothelial cancers showed moderate to strong cytoplasmic positivity. Most prostate cancers along with several malignant gliomas, lymphomas and renal cancers were moderately stained. Other malignancies were in general negative.

Validation

Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data
Supportive: Two (or more) antibodies yielding similar staining patterns which are consistent with available gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected